Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Autism Spectrum Disorder Diagnostics Market Growth From $30.37 Billion In 2026 To $36.76 Billion By 2030 At A CAGR Of 4.9%
The autism spectrum disorder diagnostics market size has experienced robust growth in recent years. This market is projected to expand from $28.87 billion in 2025 to $30.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. Historically, this growth was driven by enhanced awareness of autism spectrum disorders, the broadening of pediatric developmental screening initiatives, the presence of skilled diagnostic specialists, the increasing application of behavioral assessment models, and improved accessibility to diagnostic services.
The autism spectrum disorder diagnostics market is projected to experience consistent expansion in the coming years. Its size is anticipated to reach $36.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. This growth during the forecast period can be linked to a heightened need for early intervention services, the increasing application of AI-assisted diagnostic tools, the broadening of tele-diagnostics platforms, increased funding for neurodevelopmental research, and refined standardization of diagnostic criteria. Key trends for the same period encompass the wider embrace of digital screening instruments, more frequent utilization of standardized behavioral assessment scales, the enlargement of early childhood diagnostic initiatives, a greater incorporation of multidisciplinary diagnostic methods, and a stronger emphasis on timely and precise detection.
Get A Free Sample Report With In-Depth Market Insights:
Autism Spectrum Disorder Diagnostics Market Expansion Drivers: What’s Shaping Future Growth?
The expansion of specialized diagnostic centers is anticipated to drive the advancement of the autism spectrum disorders diagnostic market in the future. These centers are facilities where healthcare professionals, psychologists, and other specialists work together to perform thorough evaluations and assessments for the diagnosis of autism spectrum disorder. The rise in specialized diagnostic centers can be attributed to improvements in diagnostics, the need for comprehensive care, professional development, research efforts, and the acknowledgment of autism as a critical public health concern. Such centers are crucial for boosting diagnostic precision, enabling prompt intervention, and bettering results for individuals with ASD, achieved through offering specific expertise, sophisticated diagnostic instruments, complete assessments, personalized treatment strategies, family assistance, and chances for research partnerships. For example, in July 2025, as reported by NHS England, the U.K.-based government agency delivering health services, the national Community Diagnostic Centre (CDC) Programme gave its approval for 170 CDC sites across England. By August 2024, 165 sites were active in diverse environments; specifically, 135 of these are functioning from their permanent CDC building, with the remainder operating from temporary facilities until their CDC buildings are finalized. Consequently, the expansion of specialized diagnostic centers is fueling the growth of the autism spectrum disorders diagnostic market.
Autism Spectrum Disorder Diagnostics Market Segment Analysis: What Are The Core Market Categories?
The autism spectrum disorder diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools
2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests
3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults
4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes
Subsegments:
1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists
2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews
3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels
4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems
Autism Spectrum Disorder Diagnostics Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies operating within the autism spectrum disorder diagnostics market are crafting advanced solutions, such as devices leveraging Dynamic Quantification of Social-Visual Engagement (DQSVE), to secure a competitive edge. This system meticulously observes and interprets a child’s moment-by-moment gaze at a rate of 120 times per second. For example, in September 2023, the Marcus Autism Center, a US-based nonprofit healthcare and research organization, unveiled the EarliPoint™ Evaluation, a pioneering FDA-authorized device specifically designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. This innovative instrument employs eye-tracking technology to evaluate children’s social interactions, substantially decreasing the diagnostic period from multiple hours to approximately 12 minutes.
Autism Spectrum Disorder Diagnostics Market Top Companies Driving Competitive Growth
Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics
View The Full Autism Spectrum Disorder Diagnostics Market Report:
Autism Spectrum Disorder Diagnostics Market Top Region By Revenue And Market Share
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.